Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 271286 | ||
| 1:36 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Reports Third Quarter 2007 Results
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --

Enzon to Present at 11th Annual BIO CEO & Investor Conference
Enzon Reports Third Quarter 2007 Results
Enzon Files For Spin-Off of Biotech Business
Enzon Pharmaceuticals, Inc. Announces Plan To Spin-Off Biotechnology Business
